Reformulating voriconazole for inhaled therapy

Reformulating voriconazole for inhaled therapy

January 13, 2016

On Thursday 10th December 2015, Sumit Arora presented his work on the formulation of voriconazole for inhaled therapy at DDL27 in Edinburgh. It was one of the most fun and interesting lectures I have listened to in many years at a conference. His work was well carried out, well presented, and useful. I am delighted to be able to bring to you these slides and manuscript that Sumit kindly agreed for me to make public via the Aedestra website and on a number of public forum.

The slides can be found on slideshare:

Sumit’s work shows the power of inhaled engineered particles to treat invasive pulmonary aspergillosis. He demonstrates this with in vitro work, stability at 3 months and in vitro deposition, but also with in vivo studies in mice. The evidence he provides is compelling and shows yet again how the inhaled route is a viable alternative to many intravenous and oral therapies.

Thank you Sumit.

Philippe Rogueda @ Aedestra